FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Michel Pawlotsky

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Muhammad Ahmad Maqbool; Jean-Michel Pawlotsky; Sophie Carmouse; Martin R Higgs; Mohamed R Imache; Hervé Lerat
Regulation of Hepatitis C Virus Replication by Nuclear Translocation of Nonstructural 5A Protein and Transcriptional Activation of Host Genes.
Stéphane Chevaliez; Jean-Dominique Poveda; Christophe Rodriguez; Alexandre Soulier; Magali Bouvier-Alias; Jean-Michel Pawlotsky
The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.
Jean-Michel Pawlotsky
Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Michel Pawlotsky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Muhammad Ahmad Maqbool; Jean-Michel Pawlotsky; Sophie Carmouse; Martin R Higgs; Mohamed R Imache; Hervé Lerat
Regulation of Hepatitis C Virus Replication by Nuclear Translocation of Nonstructural 5A Protein and Transcriptional Activation of Host Genes.
Journal of virology 2013;87(10):5523-39.
2013: Stéphane Chevaliez; Jean-Dominique Poveda; Christophe Rodriguez; Alexandre Soulier; Magali Bouvier-Alias; Jean-Michel Pawlotsky
The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.
Journal of clinical microbiology 2013;51(4):1078-82.
2013: Jean-Michel Pawlotsky
Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?
Current gastroenterology reports 2013;15(2):309.
2013: Jean-Michel Pawlotsky
Treatment of chronic hepatitis C: current and future.
Current topics in microbiology and immunology 2013;369():321-42.
2013: Jonas Söderholm; Jesper Waldenström; Rune Wejstål; Johan Westin; Stefan Zeuzem; Galia Askarieh; Pierre-Yves Bochud; Carlo Ferrari; Bart L Haagmans; Kristoffer Hellstrand; Magnus Lindh; Gabriele Missale; Francesco Negro; Avidan U Neumann; Gunnar Norkrans; Jean-Michel Pawlotsky; Massimo Pilli; Martin Lagging
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.
PloS one 2013;8(2):e56991.
2013: Stéphanie Pascarella; Jean-Michel Pawlotsky; Laura Rubbia-Brandt; Stefan Zeuzem; Pierre-Yves Bochud; Sophie Clément; Stéphanie Conzelmann; Michael T Dill; Martin Lagging; Gabriele Missale; Avidan U Neumann; Francesco Negro
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C.
Liver international : official journal of the International Association for the Study of the Liver 2013;33(1):94-103.
2012: Philippe Chouteau; Nicole Defer; Daniel Dhumeaux; Alexandre Florimond; Aurore Gaudin; Martin Higgs; Hervé Lerat; Emilie Mérour; Julien Caldéraro; Jean-Michel Pawlotsky
Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.
Journal of hepatology 2012;57(3):499-507.
2012: Stéphane Chevaliez; Jean-Michel Pawlotsky
Virology of hepatitis C virus infection.
Best practice & research. Clinical gastroenterology 2012;26(4):381-9.
2012: Jean-Michel Pawlotsky
Is hepatitis virus resistance to antiviral drugs a threat?
Gastroenterology 2012;142(6):1369-72.
2012: Stéphane Chevaliez; Christophe Rodriguez; Jean-Michel Pawlotsky
New virologic tools for management of chronic hepatitis B and C.
Gastroenterology 2012;142(6):1303-1313.e1.
2012: Jean-Michel Pawlotsky
The science of direct-acting antiviral and host-targeted agent therapy.
Antiviral therapy 2012;17(6 Pt B):1109-17.
2012: Jean-Michel Pawlotsky; Isabel Najera; Ira Jacobson
Resistance to mericitabine, a nucleoside analogue inhibitor of HCV RNA-dependent RNA polymerase.
Antiviral therapy 2012;17(3):411-23.
2012: Geert Bezemer; Robert J de Knegt; Juan I Esteban; Carlo Ferrari; Bettina E Hansen; Martin Lagging; Yoav Lurie; Francesco Negro; Avidan U Neumann; Jean-Michel Pawlotsky; Solko W Schalm; Arthur R Van Gool; Elke Verheij-Hart; Stefan Zeuzem
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study.
BMC gastroenterology 2012;12():11.
2011: Andrew J Muir; Jean-Michel Pawlotsky; F Fred Poordad; Henk W Reesink; Mitchell L Shiffman; Stefan Zeuzem; Thomas Berg; Geoffrey Dusheiko; Peter Ferenci; Shelley George; E Jenny Heathcote; Robert S Kauffman; Emily C Martin; John G McHutchison; Nathalie Adda
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.
Hepatology (Baltimore, Md.) 2011;54(5):1538-46.
2011: P-Y Bochud; Carlo Ferrari; Bart L Haagmans; Kristoffer Hellstrand; Gabriele Missale; Francesco Negro; Avidan U Neumann; Jean-Michel Pawlotsky; S Schalm; A Soulier; Stefan Zeuzem; Stephanie Bibert; Martin Lagging
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
Journal of hepatology 2011;55(5):980-8.
2011: Romain Haudecoeur; Edwige Nicolle; Coralie Pallier; Jean-Michel Pawlotsky; Wei Yi; Abdelhakim Ahmed-Belkacem; Catherine Belle; Rozenn Brillet; Antoine Fortuné; Ahcène Boumendjel
Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Journal of medicinal chemistry 2011;54(15):5395-402.
2011: Paul Bensadoun; Stéphane Chevaliez; Martin Higgs; Christophe Rodriguez; Alexandre Soulier; Jean-Michel Pawlotsky
Genetic background of hepatocyte cell lines: are in vitro hepatitis C virus research data reliable?
Hepatology (Baltimore, Md.) 2011;54(2):748.
2011: Stéphane Chevaliez; Bruno Costes; Patrice Couzigou; Juliette Foucher; Christophe Hézode; Vincent Leroy; Ariane Mallat; Philippe Mathurin; Laurent Alric; Gérard Babany; Magali Bouvier-Alias; Jean-Pierre Bronowicki; Mariem Charaf-Eddine; Isabelle Rosa; Stéphanie Rouanet; Alexandre Soulier; Albert Tran; Jean-Michel Pawlotsky
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).
Gastroenterology 2011;141(1):119-27.
2011: Hervé Lerat; Martin Higgs; Jean-Michel Pawlotsky
Animal models in the study of hepatitis C virus-associated liver pathologies.
Expert review of gastroenterology & hepatology 2011;5(3):341-52.
2011: Jean-Michel Pawlotsky
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus.
Hepatology (Baltimore, Md.) 2011;53(5):1742-51.
2011: Jean-Michel Pawlotsky
The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending.
Gastroenterology 2011;140(3):746-54.
2011: Syria Laperche; Françoise Bouchardeau; Elisabeth André-Garnier; Vincent Thibault; Anne-Marie Roque-Afonso; Pascale Trimoulet; Ronald Colimon; Gilles Duverlie; Hélène Leguillou-Guillemette; Françoise Lunel; Magali Bouvier-Alias; Jean-Michel Pawlotsky; Cécile Henquell; Evelyne Schvoerer; Françoise Stoll-Keller; Marie-Laure Chaix; Michel Branger; Catherine Gaudy-Graffin; Arielle R Rosenberg; Bruno POZZETTO; Sophie Vallet; Yazid Baazia; Jacques Izopet; Jean-Jacques Lefrère
Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits.
Journal of clinical microbiology 2011;49(3):1113-5.
2011: Martin Lagging; Galia Askarieh; Francesco Negro; Stephanie Bibert; Jonas Söderholm; Johan Westin; Magnus Lindh; Ana Romero; Gabriele Missale; Carlo Ferrari; Avidan U Neumann; Jean-Michel Pawlotsky; Bart L Haagmans; Stefan Zeuzem; Pierre-Yves Bochud; Kristoffer Hellstrand
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.
PloS one 2011;6(2):e17232.
2011: Nezam H Afdhal; John G McHutchison; Stefan Zeuzem; alessandra mangia; Jean-Michel Pawlotsky; Jeffrey S Murray; Kevin V Shianna; Yasuhito Tanaka; David L Thomas; David R Booth; David B Goldstein
Hepatitis C pharmacogenetics: state of the art in 2010.
Hepatology (Baltimore, Md.) 2011;53(1):336-45.
2010: Ruy M Ribeiro; Georgios Germanidis; Kimberly A Powers; Bertrand Pellegrin; Paul Nikolaidis; Alan S Perelson; Jean-Michel Pawlotsky
Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections.
The Journal of infectious diseases 2010;202(9):1309-18.
2010: Stéphane Chevaliez; Magali Bouvier-Alias; Syria Laperche; Christophe Hézode; Jean-Michel Pawlotsky
Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.
Journal of clinical microbiology 2010;48(10):3641-7.
2010: Jean-Michel Pawlotsky
More sensitive hepatitis C virus RNA detection: what for?
Journal of hepatology 2010;52(6):783-5.
2010: Laetitia Barbotte; Abdelhakim Ahmed-Belkacem; Stéphane Chevaliez; Alexandre Soulier; Christophe Hézode; Henri Wajcman; Doug J Bartels; Yi Zhou; Andrzej Ardzinski; Nagraj Mani; B Govinda Rao; Shelley George; Ann D Kwong; Jean-Michel Pawlotsky
Characterization of V36C, a novel amino acid substitution conferring hepatitis C virus (HCV) resistance to telaprevir, a potent peptidomimetic inhibitor of HCV protease.
Antimicrobial agents and chemotherapy 2010;54(6):2681-3.
2010: Galia Askarieh; Asa Alsiö; Paolo Pugnale; Francesco Negro; Carlo Ferrari; Avidan U Neumann; Jean-Michel Pawlotsky; Solko W Schalm; Stefan Zeuzem; Gunnar Norkrans; Johan Westin; Jonas Söderholm; Kristoffer Hellstrand; Martin Lagging
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2010;51(5):1523-30.
2010: Jean-Michel Pawlotsky; Stéphane Chevaliez
Preventing hepatitis C virus recurrence in liver transplant recipients: a role for adoptive immunotherapy?
Hepatology (Baltimore, Md.) 2010;51(3):1072-6.
2010: Abdelhakim Ahmed-Belkacem; Nazim Ahnou; Laetitia Barbotte; Czeslaw Wychowski; Coralie Pallier; Rozenn Brillet; Ralf-Torsten Pohl; Jean-Michel Pawlotsky
Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Gastroenterology 2010;138(3):1112-22.
2010: Jean-Michel Pawlotsky; Laurence Cocquerel; David Durantel; Dimitri Lavillette; Hervé Lerat; Eve-Isabelle Pécheur; Stephen J Polyak; Norbert Tautz; Robert Thimme
HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses.
Gastroenterology 2010;138(1):6-12.e1-2.
2009: Jean-Michel Pawlotsky
Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
Therapeutic advances in gastroenterology 2009;2(4):205-19.
2009: Jean-Michel Pawlotsky
Hepatitis: HCV variability, the immune system and resistance to antiviral drugs.
Nature reviews. Gastroenterology & hepatology 2009;6(7):383-5.
2009: Stéphane Chevaliez; Magali Bouvier-Alias; Jean-Michel Pawlotsky
Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification.
Journal of clinical microbiology 2009;47(6):1726-32.
2009: Yoann Morice; Maxime Ratinier; Ahmed Miladi; Stéphane Chevaliez; Georgios Germanidis; Heiner Wedemeyer; Syria Laperche; Jean-Pierre Lavergne; Jean-Michel Pawlotsky
Seroconversion to hepatitis C virus alternate reading frame protein during acute infection.
Hepatology (Baltimore, Md.) 2009;49(5):1449-59.
2009: Christophe Hézode; Nicole Forestier; Geoffrey Dusheiko; Peter Ferenci; Stanislas Pol; Tobias Goeser; Jean-Pierre Bronowicki; Marc Bourlière; SHAHIN GHARAKHANIAN; Leif Bengtsson; Lindsay McNair; Shelley George; Tara Kieffer; Ann Kwong; Robert S Kauffman; John Alam; Jean-Michel Pawlotsky; Stefan Zeuzem
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
The New England journal of medicine 2009;360(18):1839-50.
2009: Stéphane Chevaliez; Magali Bouvier-Alias; Laurent Castéra; Jean-Michel Pawlotsky
The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples.
Hepatology (Baltimore, Md.) 2009;49(4):1397-8.
2009: Jean-Michel Pawlotsky
EASL Clinical Practice Guidelines.
Journal of hepatology 2009;50(2):243.
2009: Stéphane Chevaliez; Magali Bouvier-Alias; Rozenn Brillet; Jean-Michel Pawlotsky
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.
PloS one 2009;4(12):e8209.
2009: Stéphane Chevaliez; Jean-Michel Pawlotsky
Virological techniques for the diagnosis and monitoring of hepatitis B and C.
Annals of hepatology 2009;8(1):7-12.
2009: Stéphane Chevaliez; Jean-Michel Pawlotsky
How to use virological tools for optimal management of chronic hepatitis C.
Liver international : official journal of the International Association for the Study of the Liver 2009;29 Suppl 1():9-14.
2009: Coralie Pallier; Christophe Rodriguez; Rozenn Brillet; patrice nordmann; Christophe Hézode; Jean-Michel Pawlotsky
Complex dynamics of hepatitis B virus resistance to adefovir.
Hepatology (Baltimore, Md.) 2009;49(1):50-9.
2009: Stéphane Chevaliez; Jean-Michel Pawlotsky
Interferons and their use in persistent viral infections.
Handbook of experimental pharmacology 2009;(189):203-41.
2008: Giovanni Raimondo; Jean-Pierre Allain; Maurizia R Brunetto; Marie Annick Buendia; Ding-Shinn Chen; Massimo Colombo; Antonio Craxì; Francesco Donato; Carlo Ferrari; Giovanni B Gaeta; Wolfram H Gerlich; Massimo Levrero; Stephen Locarnini; Thomas Michalak; Mario U Mondelli; Jean-Michel Pawlotsky; Teresa Pollicino; Daniele Prati; Massimo Puoti; Didier Samuel; Daniel Shouval; Antonina Smedile; Giovanni Squadrito; Christian Trépo; Erica Villa; Hans Will; Alessandro R Zanetti; Fabien Zoulim
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
Journal of hepatology 2008;49(4):652-7.
2008: Dominique Challine; Stéphane Chevaliez; Jean-Michel Pawlotsky
Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
Gastroenterology 2008;135(4):1185-91.
2008: Emmanuelle Girou; Stéphane Chevaliez; Dominique Challine; Michaël Thiessart; Yoann Morice; Philippe Lesprit; Latifa Tkoub-Scheirlinck; Sophan Soing-Altrach; Florence Cizeau; Celine Cavin; Martine André; Djamel Dahmanne; Philippe Lang; Jean-Michel Pawlotsky
Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(5):627-33.
2008: Aurélie Piodi; Philippe Chouteau; Hervé Lerat; Christophe Hézode; Jean-Michel Pawlotsky
Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
Hepatology (Baltimore, Md.) 2008;48(1):16-27.
2008: Georgios Germanidis; Simeon Metallidis; Georgia Lazaraki; Jean-Michel Pawlotsky; Paul Nikolaidis
NS5A sequences of hepatitis C virus genotype 1 and interferon resistance: where are we?
The Journal of infectious diseases 2008;198(1):154-5.
2008: Paolo Pugnale; Eva Herrmann; Avidan U Neumann; Jean-Michel Pawlotsky; Solko W Schalm; Carlo Ferrari; Yonit Homburger; Stefan Zeuzem; Francesco Negro
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
Journal of hepatology 2008;48(6):932-8.
2008: Jean-Michel Pawlotsky
Building a liver disease policy in the European Union.
Journal of hepatology 2008;48(6):889-91.
2008: Stéphane Chevaliez; Magali Bouvier-Alias; Syria Laperche; Jean-Michel Pawlotsky
Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.
Journal of clinical microbiology 2008;46(5):1716-23.
2008: Emmet B Keeffe; Douglas T Dieterich; Jean-Michel Pawlotsky; Yves Benhamou
Chronic hepatitis B: preventing, detecting, and managing viral resistance.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(3):268-74.
2008: Jean-Michel Pawlotsky; Geoffrey Dusheiko; Angelos Hatzakis; Daryl Lau; George Lau; TSANYANG LIANG; Stephen Locarnini; Paul Martin; Douglas D Richman; Fabien Zoulim
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.
Gastroenterology 2008;134(2):405-15.
2008: Susan Smyk-Pearson; Ian A Tester; Jared Klarquist; Brent E Palmer; Jean-Michel Pawlotsky; Lucy Golden-Mason; Hugo Rosen
Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.
Journal of virology 2008;82(4):1827-37.
2008: Stéphane Chevaliez; Jean-Michel Pawlotsky
Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
Best practice & research. Clinical gastroenterology 2008;22(6):1031-48.
2008: Johan Westin; Magdalena Ydreborg; Sara Islam; Asa Alsiö; Amar P Dhillon; Jean-Michel Pawlotsky; Stefan Zeuzem; Solko W Schalm; Carlo Ferrari; Avidan U Neumann; Kristoffer Hellstrand; Martin Lagging
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection.
Scandinavian journal of gastroenterology 2008;43(1):73-80.
2008: Jean-Michel Pawlotsky
[Virologic techniques for the diagnosis and monitoring of hepatitis B].
Gastroentérologie clinique et biologique 2008;32(1 Pt 2):S56-63.
2007: S Chevaliez; Jean-Michel Pawlotsky
Practical use of hepatitis C virus kinetics monitoring in the treatment of chronic hepatitis C.
Journal of viral hepatitis 2007;14 Suppl 1():77-81.
2007: Syria Laperche; Françoise Bouchardeau; Vincent Thibault; Bruno POZZETTO; Sophie Vallet; Arielle R Rosenberg; Anne-Marie Roque-Afonso; Michelle Gassin; Françoise Stoll-Keller; Pascale Trimoulet; Elyanne Gault; Bruno Chanzy; Bernard Mercier; Michel Branger; Jean-Michel Pawlotsky; Cécile Henquell; Françoise Lunel; Catherine Gaudy-Graffin; Sophie Alain; Marie-Laure Chaix; Gilles Duverlie; Jacques Izopet; Jean-Jacques Lefrère
Multicenter trials need to use the same assay for hepatitis C virus viral load determination.
Journal of clinical microbiology 2007;45(11):3788-90.
2007: Stéphane Chevaliez; Jean-Michel Pawlotsky
Interferon-based therapy of hepatitis C.
Advanced drug delivery reviews 2007;59(12):1222-41.
2007: Evaldo Stanislau Affonso de Araújo; João Silva Mendonça; Antonio Alci Barone; Fernando Lopes Gonçales; Marcelo Simão Ferreira; Roberto Focaccia; Jean-Michel Pawlotsky
Consensus of the Brazilian Society of Infectious Diseases on the management and treatment of hepatitis C.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2007;11(5):446-50.
2007: Massimo Pilli; Alessandro Zerbini; Amalia Penna; Alessandra Orlandini; Esther Lukasiewicz; Jean-Michel Pawlotsky; Stefan Zeuzem; Solko W Schalm; Michael von Wagner; Georgios Germanidis; Yoav Lurie; Juan I Esteban; Bart L Haagmans; Christophe Hezode; Martin Lagging; Francesco Negro; Yonit Homburger; Avidan U Neumann; Carlo Ferrari; Gabriele Missale
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
Gastroenterology 2007;133(4):1132-43.
2007: Patrick Marcellin; Marc Bourlière; Jean-Michel Pawlotsky; Denis Ouzan
[HCV non-responder patients: definition of non-response and treatment strategy].
Gastroentérologie clinique et biologique 2007;31(8-9 Pt 3):4S13-9.
2007: Anna S F Lok; Fabien Zoulim; Stephen Locarnini; Angeline Bartholomeusz; Marc G Ghany; Jean-Michel Pawlotsky; Yun-Fan Liaw; Masashi Mizokami; Carla Kuiken
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
Hepatology (Baltimore, Md.) 2007;46(1):254-65.
2007: Stéphane Chevaliez; Magali Bouvier-Alias; Rozenn Brillet; Jean-Michel Pawlotsky
Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.
Hepatology (Baltimore, Md.) 2007;46(1):22-31.
2007: Stéphane Chevaliez; Rozenn Brillet; Ester Lázaro; Christophe Hézode; Jean-Michel Pawlotsky
Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
Journal of virology 2007;81(14):7732-41.
2007: Stéphane Chevaliez; Jean-Michel Pawlotsky
Hepatitis C virus: virology, diagnosis and management of antiviral therapy.
World journal of gastroenterology : WJG 2007;13(17):2461-6.
2007: Jean-Michel Pawlotsky; Stéphane Chevaliez; John G McHutchison
The hepatitis C virus life cycle as a target for new antiviral therapies.
Gastroenterology 2007;132(5):1979-98.
2007: Johan Westin; Kristoffer Hellstrand; Asa Alsiö; Magdalena Ydreborg; Carlo Ferrari; Avidan U Neumann; Jean-Michel Pawlotsky; Solko W Schalm; Stefan Zeuzem; Elke Verhey-Hart; Martin Lagging
Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2007;45(5):1333-4; author reply 1334.
2007: Christophe Hézode; Stéphane Chevaliez; Magali Bouvier-Alias; Françoise Roudot-Thoraval; Rozenn Brillet; Elie Serge Zafrani; Daniel Dhumeaux; Jean-Michel Pawlotsky
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.
Journal of hepatology 2007;46(5):791-6.
2007: Jean-Michel Pawlotsky
Treatment of hepatitis C: don't put all your eggs in one basket!
Gastroenterology 2007;132(4):1611-5.
2007: Françoise Bouchardeau; Jean-François Cantaloube; Stéphane Chevaliez; Christine Portal; Annie Razer; Jean-Jacques Lefrère; Jean-Michel Pawlotsky; Philippe de Micco; Syria Laperche
Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay.
Journal of clinical microbiology 2007;45(4):1140-5.
2007: Rozenn Brillet; François Penin; Christophe Hezode; Philippe Chouteau; Daniel Dhumeaux; Jean-Michel Pawlotsky
The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
The Journal of infectious diseases 2007;195(3):432-41.
2007: Ioannis Griveas; Georgios Germanidis; George Visvardis; Yoann Morice; A S Perelson; Jean-Michel Pawlotsky; Dorothea Papadopoulou
Acute hepatitis C in patients receiving hemodialysis.
Renal failure 2007;29(6):731-6.
2007: Johan Westin; Martin Lagging; Amar P Dhillon; Gunnar Norkrans; Ana I Romero; Jean-Michel Pawlotsky; Stefan Zeuzem; Solko W Schalm; Elke Verheij-Hart; Francesco Negro; Gabriele Missale; Avidan U Neumann; Kristoffer Hellstrand
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.
Journal of viral hepatitis 2007;14(1):29-35.
2007: Esther Lukasiewicz; Kristoffer Hellstrand; Johan Westin; Carlo Ferrari; Avidan U Neumann; Jean-Michel Pawlotsky; Solko W Schalm; Stefan Zeuzem; Bart J Veldt; Bettina E Hansen; Elke Verhey-Hart; Martin Lagging
Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
Hepatology (Baltimore, Md.) 2007;45(1):258-9.
2007: Christophe Combet; Nicolas Garnier; Céline Charavay; Delphine Grando; Daniel Crisan; Julien Lopez; Alexandre Dehne-Garcia; Christophe Geourjon; Emmanuel Bettler; Chantal Hulo; Philippe Le Mercier; Ralf Bartenschlager; Helmut M Diepolder; Darius Moradpour; Jean-Michel Pawlotsky; Charles M Rice; Christian Trépo; François Penin; Gilbert Deléage
euHCVdb: the European hepatitis C virus database.
Nucleic acids research 2007;35(Database issue):D363-6.
2006: Martin Lagging; Ana I Romero; Johan Westin; Gunnar Norkrans; Amar P Dhillon; Jean-Michel Pawlotsky; Stefan Zeuzem; Michael von Wagner; Francesco Negro; Solko W Schalm; Bart L Haagmans; Carlo Ferrari; Gabriele Missale; Avidan U Neumann; Elke Verheij-Hart; Kristoffer Hellstrand
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
Hepatology (Baltimore, Md.) 2006;44(6):1617-25.
2006: L Perrin; Jean-Michel Pawlotsky; Magali Bouvier-Alias; C Sarrazin; S Zeuzem; G Colucci
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load.
Journal of clinical microbiology 2006;44(12):4371-5.
2006: Carla Kuiken; Christophe Combet; Jens Bukh; Tadasu Shin-i; Gilbert Deleage; Masashi Mizokami; Russell Richardson; Erwin Sablon; Karina Yusim; Jean-Michel Pawlotsky; Peter Simmonds
A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes.
Hepatology (Baltimore, Md.) 2006;44(5):1355-61.
2006: Jean-Pierre Bronowicki; Denis Ouzan; Tarik Asselah; Hervé Desmorat; Jean-Pierre Zarski; Juliette Foucher; Marc Bourlière; Christophe Renou; Albert Tran; Pascal Melin; Christophe Hézode; Michelle Chevalier; Magali Bouvier-Alias; Stéphane Chevaliez; François Montestruc; Isabelle Lonjon-Domanec; Jean-Michel Pawlotsky
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
Gastroenterology 2006;131(4):1040-8.
2006: Syria Laperche; Vincent Thibault; Françoise Bouchardeau; Sophie Alain; Sandrine Castelain; Michelle Gassin; Marie Gueudin; Philippe Halfon; Sylvie Larrat; Françoise Lunel; Michèle Martinot-Peignoux; Bernard Mercier; Jean-Michel Pawlotsky; Bruno POZZETTO; Anne-Marie Roque-Afonso; Françoise Roudot-Thoraval; Karine Sauné; Jean-Jacques Lefrère
Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.
Journal of clinical microbiology 2006;44(10):3600-7.
2006: Ana I Romero; Martin Lagging; Johan Westin; Amar P Dhillon; Lynn B Dustin; Jean-Michel Pawlotsky; Avidan U Neumann; Carlo Ferrari; Gabriele Missale; Bart L Haagmans; Solko W Schalm; Stefan Zeuzem; Francesco Negro; Elke Verheij-Hart; Kristoffer Hellstrand
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
The Journal of infectious diseases 2006;194(7):895-903.
2006: Yoann Morice; Jean-François Cantaloube; Stéphanie Beaucourt; Laetitia Barbotte; Sija De Gendt; Fernando Lopes Goncales; Lesley Butterworth; Graham Cooksley; Robert G Gish; Michel Beaugrand; Fabian Fay; Oscar Fay; Jorge E Gonzalez; Regina M B Martins; Daniel Dhumeaux; Bart Vanderborght; Lieven Stuyver; Erwin Sablon; Xavier de Lamballerie; Jean-Michel Pawlotsky
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.
Journal of medical virology 2006;78(10):1296-303.
2006: Dominique Challine; Françoise Roudot-Thoraval; Patrick Sabatier; Fabienne Dubernet; Patrick Larderie; Pierrette Rigot; Jean-Michel Pawlotsky
Serological viral testing of cadaveric cornea donors.
Transplantation 2006;82(6):788-93.
2006: Jean-Michel Pawlotsky
Science, medicine and... the markets.
Journal of hepatology 2006;45(3):341-2.
2006: Jean-Michel Pawlotsky
[New therapeutic strategies in chronic hepatitis C].
Gastroentérologie clinique et biologique 2006;30(8-9):1009-11.
2006: Syria Laperche; Karine Saune; Paul Dény; Gilles Duverlie; Sophie Alain; Marie-Laure Chaix; Catherine Gaudy; Françoise Lunel; Jean-Michel Pawlotsky; Christopher Payan; Bruno POZZETTO; Catherine Tamalet; Vincent Thibault; Sophie Vallet; Françoise Bouchardeau; Jacques Izopet; Jean-Jacques Lefrère
Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies.
Journal of clinical microbiology 2006;44(2):614-6.
2006: Jean-Michel Pawlotsky
Therapy of hepatitis C: from empiricism to eradication.
Hepatology (Baltimore, Md.) 2006;43(2 Suppl 1):S207-20.
2006: John G McHutchison; Ralf Bartenschlager; Keyur Patel; Jean-Michel Pawlotsky
The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
Journal of hepatology 2006;44(2):411-21.
2006: Jean-Michel Pawlotsky; Robert G Gish
Future therapies for hepatitis C.
Antiviral therapy 2006;11(4):397-408.
2006: Stéphane Chevaliez; Jean-Michel Pawlotsky
Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease.
International journal of medical sciences 2006;3(2):35-40.
2006: Coralie Pallier; Laurent Castéra; Alexandre Soulier; Christophe Hézode; patrice nordmann; Daniel Dhumeaux; Jean-Michel Pawlotsky
Dynamics of hepatitis B virus resistance to lamivudine.
Journal of virology 2006;80(2):643-53.
2006: Jean-Michel Pawlotsky
Virology of hepatitis B and C viruses and antiviral targets.
Journal of hepatology 2006;44(1 Suppl):S10-3.
2005: Jean-Michel Pawlotsky
The concept of hepatitis B virus mutant escape.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34 Suppl 1():S125-9.
2005: Nathalie Callens; Yann Ciczora; Birke Bartosch; Ngoc Vu-Dac; François-Loïc Cosset; Jean-Michel Pawlotsky; François Penin; Jean Dubuisson
Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.
Journal of virology 2005;79(24):15331-41.
2005: Peter Simmonds; Jens Bukh; Christophe Combet; Gilbert Deléage; Nobuyuki Enomoto; Stephen Feinstone; Phillippe Halfon; Geneviève Inchauspé; Carla Kuiken; Geert Maertens; Masashi Mizokami; Donald G Murphy; Hiroaki Okamoto; Jean-Michel Pawlotsky; François Penin; Erwin Sablon; Tadasu Shin-i; Lieven Stuyver; Heinz-Jürgen Thiel; Sergei Viazov; Amy J Weiner; Anders Widell
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.
Hepatology (Baltimore, Md.) 2005;42(4):962-73.
2005: Stefan Zeuzem; Jean-Michel Pawlotsky; Esther Lukasiewicz; Michael von Wagner; Ioannis Goulis; Yoav Lurie; Elia Gianfranco; Jan M Vrolijk; Juan I Esteban; Christophe Hezode; Martin Lagging; Francesco Negro; Alexandre Soulier; Elke Verheij-Hart; Bettina Hansen; Ronen Tal; Carlo Ferrari; Solko W Schalm; Avidan U Neumann
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C.
Journal of hepatology 2005;43(2):250-7.
2005: Stéphane Chevaliez; Jean-Michel Pawlotsky
Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
Clinics in liver disease 2005;9(3):371-82, v.
2005: Birke Bartosch; Géraldine Verney; Marlène Dreux; Peggy Donot; Yoann Morice; François Penin; Jean-Michel Pawlotsky; Dimitri Lavillette; François-Loïc Cosset
An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.
Journal of virology 2005;79(13):8217-29.
2005: Christophe Hézode; Françoise Roudot-Thoraval; Son Nguyen; Pascale Grenard; Boris Julien; Elie Serge Zafrani; Jean-Michel Pawlotsky; Jean-Michel Pawlostky; Daniel Dhumeaux; Sophie Lotersztajn; Ariane Mallat
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2005;42(1):63-71.
2005: Dimitri Lavillette; Yoann Morice; Georgios Germanidis; Peggy Donot; Alexandre Soulier; Emanuil Pagkalos; Georgios Sakellariou; Liliane Intrator; Birke Bartosch; Jean-Michel Pawlotsky; François-Loïc Cosset
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
Journal of virology 2005;79(10):6023-34.
2005: Karine Gourlain; Alexandre Soulier; Bertrand Pellegrin; Magali Bouvier-Alias; Christophe Hézode; Françoise Darthuy; Jocelyne Rémiré; Jean-Michel Pawlotsky
Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.
Journal of clinical microbiology 2005;43(4):1669-73.
2005: Stéphane Chevaliez; Jean-Michel Pawlotsky
[Screening and diagnosis of hepatitis B and C].
La Revue du praticien 2005;55(6):615-23.
2005: Laurent Castera; Philippe Chouteau; Christophe Hezode; Elie Serge Zafrani; Daniel Dhumeaux; Jean-Michel Pawlotsky
Hepatitis C virus-induced hepatocellular steatosis.
The American journal of gastroenterology 2005;100(3):711-5.
2005: Jean-Michel Pawlotsky
Current and future concepts in hepatitis C therapy.
Seminars in liver disease 2005;25(1):72-83.
2005: Syria Laperche; Françoise Lunel; Jacques Izopet; Sophie Alain; Paul Dény; Gilles Duverlie; Catherine Gaudy; Jean-Michel Pawlotsky; Jean-Christophe Plantier; Bruno POZZETTO; Vincent Thibault; François Tosetti; Jean-Jacques Lefrère
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study.
Journal of clinical microbiology 2005;43(2):733-9.
2005: Laurent Castera; Jean-Michel Pawlotsky
Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C.
MedGenMed : Medscape general medicine 2005;7(4):39.
2004: Muriel Soler; John G McHutchison; T Jesse Kwoh; F Andrew Dorr; Jean-Michel Pawlotsky
Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Antiviral therapy 2004;9(6):953-68.
2004: Keyur Patel; Stuart Gordon; Ira Jacobson; Christophe Hézode; Esther Oh; Katie M Smith; Jean-Michel Pawlotsky; John G McHutchison
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Journal of hepatology 2004;41(6):935-42.
2004: Jean-Michel Pawlotsky
Hepatitis C: it's a long way to new therapy, it's a long way to go...
Gastroenterology 2004;127(5):1629-32.
2004: Dominique Challine; Bertrand Pellegrin; Magali Bouvier-Alias; Pierrette Rigot; Liliane Laperche; Jean-Michel Pawlotsky
HIV and hepatitis C virus RNA in seronegative organ and tissue donors.
Lancet 2004;364(9445):1611-2.
2004: Stephen Locarnini; Angelos Hatzakis; Jenny Heathcote; Emmet B Keeffe; TSANYANG LIANG; David Mutimer; Jean-Michel Pawlotsky; Fabien Zoulim
Management of antiviral resistance in patients with chronic hepatitis B.
Antiviral therapy 2004;9(5):679-93.
2004: Christophe Hézode; Françoise Roudot-Thoraval; Elie Serge Zafrani; Daniel Dhumeaux; Jean-Michel Pawlotsky
Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
Journal of viral hepatitis 2004;11(5):455-8.
2004: Jean-Michel Pawlotsky
Treating hepatitis C in "difficult-to-treat" patients.
The New England journal of medicine 2004;351(5):422-3.
2004: Jean-Jacques Lefrère; Françoise Roudot-Thoraval; Françoise Lunel; Sophie Alain; Marie-Laure Chaix; Elisabeth Dussaix; Michelle Gassin; Jacques Izopet; Jean-Michel Pawlotsky; Christopher Payan; Françoise Stoll-Keller; Vincent Thibault; Mary-Anne Trabaud; Dominique Bettinger; Marc Bogard; Michel Branger; Claudine Buffet-Janvresse; Anne Charrois; Christine Defer; Catherine Laffont; Joëlle Lerable; Thierry Levayer; Michèle Martinot-Peignoux; Bernard Mercier; Arielle R Rosenberg
Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum.
Journal of clinical microbiology 2004;42(5):2027-30.
2004: Muriel Pellerin; Yolanda Lopez-Aguirre; François Penin; Daniel Dhumeaux; Jean-Michel Pawlotsky
Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus-host interactions.
Journal of virology 2004;78(9):4617-27.
2004: Jean-Michel Pawlotsky; Harel Dahari; Avidan U Neumann; Christophe Hezode; Georgios Germanidis; Isabelle Lonjon; Laurent Castera; Daniel Dhumeaux
Antiviral action of ribavirin in chronic hepatitis C.
Gastroenterology 2004;126(3):703-14.
2004: Laurent Castéra; Christophe Hézode; Françoise Roudot-Thoraval; Isabelle Lonjon; Elie Serge Zafrani; Jean-Michel Pawlotsky; Daniel Dhumeaux
Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
Gut 2004;53(3):420-4.
2004: Jean-Michel Pawlotsky
Pathophysiology of hepatitis C virus infection and related liver disease.
Trends in microbiology 2004;12(2):96-102.
2004: Jean-Michel Pawlotsky; John G McHutchison
Hepatitis C. Development of new drugs and clinical trials: promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003.
Hepatology (Baltimore, Md.) 2004;39(2):554-67.
2004: François Penin; Jean Dubuisson; Felix A Rey; Darius Moradpour; Jean-Michel Pawlotsky
Structural biology of hepatitis C virus.
Hepatology (Baltimore, Md.) 2004;39(1):5-19.
2004: Owonayo Oniankitan; Christophe Duvoux; Dominique Challine; Ariane Mallat; Xavier Chevalier; Jean-Michel Pawlotsky; Pascal Claudepierre
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C.
The Journal of rheumatology 2004;31(1):107-9.
2003: Christophe Hezode; Laurent Castera; Philippe Chouteau; Daniel Dhumeaux; Jean-Michel Pawlotsky
[Steasis and hepatitis C].
Gastroentérologie clinique et biologique 2003;27(12):1091-5.
2003: Jean-Michel Pawlotsky
The nature of interferon-alpha resistance in hepatitis C virus infection.
Current opinion in infectious diseases 2003;16(6):587-92.
2003: Jean-Michel Pawlotsky
Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C.
Antiviral research 2003;59(1):1-11.
2003: Christophe Hézode; Isabelle Lonjon; Françoise Roudot-Thoraval; Jean-Michel Pawlotsky; Elie Serge Zafrani; Daniel Dhumeaux
Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study.
Alimentary pharmacology & therapeutics 2003;17(8):1031-7.
2003: François-Jérôme Authier; guillaume bassez; C Payan; L Guillevin; Jean-Michel Pawlotsky; Jean-Denis Degos; Romain K Gherardi; Laurent Belec
Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy.
Neurology 2003;60(5):808-12.
2003: Jean-Michel Pawlotsky
Use and interpretation of hepatitis C virus diagnostic assays.
Clinics in liver disease 2003;7(1):127-37.
2003: Jean-Michel Pawlotsky
Hepatitis C virus genetic variability: pathogenic and clinical implications.
Clinics in liver disease 2003;7(1):45-66.
2003: Thomas Bourlet; Rachel Levy; Silvy Laporte; Stéphane Blachier; Laurence Bocket; Guy Cassuto; Lionel Chollet; Marianne Leruez-Ville; Anne Maertens; Fabienne Mousnier; Christophe Pasquier; Christopher Payan; Bertrand Pellegrin; Evelyne Schvoerer; Patricia Zavadzki; Jacques Chouteau; Gilles Duverlie; Jacques Izopet; Françoise Lunel-Fabiani; Jean-Michel Pawlotsky; Nerina Profizi; Christine Rouzioux; Françoise Stoll-Keller; Vincent Thibault; Pierre Wattré; Bruno POZZETTO
Multicenter quality control for the detection of hepatitis C virus RNA in seminal plasma specimens.
Journal of clinical microbiology 2003;41(2):789-93.
2003: Laurent Castéra; Christophe Hézode; Françoise Roudot-Thoraval; Anne Bastie; Elie Serge Zafrani; Jean-Michel Pawlotsky; Daniel Dhumeaux
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
Gut 2003;52(2):288-92.
2003: Jean-Michel Pawlotsky
Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics.
Journal of hepatology 2003;39 Suppl 1():S31-5.
2003: Jean-Michel Pawlotsky
Diagnostic testing in hepatitis C virus infection: viral kinetics and genomics.
Seminars in liver disease 2003;23 Suppl 1():3-11.
2003: Christophe Hézode; Isabelle Lonjon; Françoise Roudot-Thoraval; J-P Mavier; Jean-Michel Pawlotsky; Elie Serge Zafrani; Daniel Dhumeaux
Impact of smoking on histological liver lesions in chronic hepatitis C.
Gut 2003;52(1):126-9.
2002: Jean-Michel Pawlotsky
Use and interpretation of virological tests for hepatitis C.
Hepatology (Baltimore, Md.) 2002;36(5 Suppl 1):S65-73.
2002: Valérie Castet; Chantal Fournier; Alexandre Soulier; Rozenn Brillet; Joliette Coste; Dominique Larrey; Daniel Dhumeaux; Patrick Maurel; Jean-Michel Pawlotsky
Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro.
Journal of virology 2002;76(16):8189-99.
2002: Dominique Challine; Marlyse Buisson; Michel Cadilhac; Georgios Germanidis; Irene Joab; Muriel Eliaszewicz; Eric Caumes; Antoine Flahault; Anne-Marie Fillet; Jean-Michel Pawlotsky; Jean-Marie Seigneurin
Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Journal of medical virology 2002;67(4):510-5.
2002: Magali Bouvier-Alias; Keyur Patel; Harel Dahari; Stéphanie Beaucourt; Patrick Larderie; Lawrence Blatt; Christophe Hezode; Gaston Picchio; Daniel Dhumeaux; Avidan U Neumann; John G McHutchison; Jean-Michel Pawlotsky
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.
Hepatology (Baltimore, Md.) 2002;36(1):211-8.
2002: Muriel Soler; Muriel Pellerin; Cécile MALNOU; Daniel Dhumeaux; Katherine M Kean; Jean-Michel Pawlotsky
Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.
Virology 2002;298(1):160-73.
2002: Jean-Michel Pawlotsky
Molecular diagnosis of viral hepatitis.
Gastroenterology 2002;122(6):1554-68.
2002: Jean-Michel Pawlotsky
[Management of patients with hepatitis C virus infection. Virological tests].
Gastroentérologie clinique et biologique 2002;26 Spec No 2():B180-7.
2002: Rafael Quadri; Emiliano Giostra; Tania Roskams; Jean-Michel Pawlotsky; Gilles Mentha; Laura Rubbia-Brandt; Luc Perrin; Antoine Hadengue; Francesco Negro
Immunological and virological effects of ribavirin in hepatitis C after liver transplantation.
Transplantation 2002;73(3):373-8.
2002: Christophe Duvoux; Anh Tran Ngoc; Liliane Intrator; Christophe Hézode; Georgios Germanidis; Jean-Michel Pawlotsky; Daniel Cherqui; Daniel Dhumeaux
Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
Transplant international : official journal of the European Society for Organ Transplantation 2002;15(1):3-9.
2001: Dominique Challine; Françoise Roudot-Thoraval; T Sarah; L Laperche; B Boisson; S Mauberquez; F Dubernet; Pierrette Rigot; François Lefrère; Bernard Mercier; Yves Brossard; F Rouet; Robert Girot; Pascale Loiseau; D Girard; Jacky Claquin; Bernard Loty; Joëlle Lerable; Martine Mariotti; Jean-Michel Pawlotsky; Jean-Jacques Lefrère
Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses.
Transfusion 2001;41(9):1120-5.
2001: François Penin; Christophe Combet; Georgios Germanidis; PO Frainais; Gilbert Deléage; Jean-Michel Pawlotsky
Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
Journal of virology 2001;75(12):5703-10.
2001: Jean-Michel Pawlotsky
[Hepatitis C virus and immune response].
Gastroentérologie clinique et biologique 2001;25(4 Suppl):B123-33.
2000: Jean-Michel Pawlotsky
Hepatitis C virus resistance to antiviral therapy.
Hepatology (Baltimore, Md.) 2000;32(5):889-96.
2000: Jean-Michel Pawlotsky; Magali Bouvier-Alias; Christophe Hezode; Françoise Darthuy; J Remire; Daniel Dhumeaux
Standardization of hepatitis C virus RNA quantification.
Hepatology (Baltimore, Md.) 2000;32(3):654-9.
2000: Jean-Jacques Lefrère; Joëlle Lerable; Martine Mariotti; Marc Bogard; Vincent Thibault; L Frangeul; Pascale Loiseau; Françoise Bouchardeau; Syria Laperche; Jean-Michel Pawlotsky; Jean-François Cantaloube; Philippe Biagini; Xavier de Lamballerie; Jacques Izopet; Christine Defer; I Lepot; J D Poveda; Elisabeth Dussaix; Victoria Gerolami; Philippe Halfon; Claudine Buffet-Janvresse; C Férec; Bernard Mercier; P Marcellin; Michèle Martinot-Peignoux; M Gassain
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.
Journal of virological methods 2000;85(1-2):117-24.
2000: Jean-Michel Pawlotsky; Anne Bastie; Christophe Hézode; Isabelle Lonjon; Françoise Darthuy; Jocelyne Rémiré; Daniel Dhumeaux
Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays.
Journal of virological methods 2000;85(1-2):11-21.
2000: Anne Bastie; L Castera; Françoise Roudot-Thoraval; Daniel Dhumeaux; Jean-Michel Pawlotsky
Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: a wrong track.
Hepatology (Baltimore, Md.) 2000;31(2):547-8.
1999: Christophe Hézode; Cécile Cazeneuve; O Coué; Françoise Roudot-Thoraval; Isabelle Lonjon; Anne Bastie; Christophe Duvoux; Jean-Michel Pawlotsky; Elie Serge Zafrani; Serge Amselem; Daniel Dhumeaux
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.
Journal of hepatology 1999;31(6):979-84.
1999: Jean-Michel Pawlotsky; Daniel Dhumeaux
[The G virus: the orphan virus].
Presse médicale (Paris, France : 1983) 1999;28(34):1882-3.
1999: Michèle Martinot-Peignoux; Françoise Roudot-Thoraval; I Mendel; J Coste; Jacques Izopet; Gilles Duverlie; Christopher Payan; Jean-Michel Pawlotsky; Christine Defer; Marc Bogard; Victoria Gerolami; Philippe Halfon; Y Buisson; B Fouqueray; P Loiseau; J Lamoril; J J Lefrere; P Marcellin
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP.
Journal of viral hepatitis 1999;6(6):435-43.
1999: Christophe Duvoux; Jean-Michel Pawlotsky; Anne Bastie; Daniel Cherqui; CJ Soussy; Daniel Dhumeaux
Low HCV replication levels in end-stage hepatitis C virus-related liver disease.
Journal of hepatology 1999;31(4):593-7.
1999: Jean-Michel Pawlotsky; Georgios Germanidis
The non-structural 5A protein of hepatitis C virus.
Journal of viral hepatitis 1999;6(5):343-56.
1999: Georgios Germanidis; C haioun; Daniel Dhumeaux; F Reyes; Jean-Michel Pawlotsky
Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphoma.
Hepatology (Baltimore, Md.) 1999;30(3):822-3.
1999: Christophe Hézode; Christophe Duvoux; Georgios Germanidis; Françoise Roudot-Thoraval; A L Vincens; Philippe Gaulard; Daniel Cherqui; Jean-Michel Pawlotsky; Daniel Dhumeaux
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.
Hepatology (Baltimore, Md.) 1999;30(3):775-8.
1999: Jean-Michel Pawlotsky; Georgios Germanidis; PO Frainais; M Bouvier; Alexandre Soulier; Muriel Pellerin; Daniel Dhumeaux
Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy.
Journal of virology 1999;73(8):6490-9.
1999: Jean-Michel Pawlotsky
Hepatitis C virus (HCV) NS5A protein: role in HCV replication and resistance to interferon-alpha.
Journal of viral hepatitis 1999;6 Suppl 1():47-8.
1999: Laurent Castera; Daniel Dhumeaux; Jean-Michel Pawlotsky
[The role of virologic tests in the treatment of chronic hepatitis C].
Gastroentérologie clinique et biologique 1999;23(6-7):707-9.
1999: Jean-Jacques Lefrère; Jean-François Cantaloube; Christine Defer; Bernard Mercier; Pascale Loiseau; D Vignon; Jean-Michel Pawlotsky; Philippe Biagini; Joëlle Lerable; Philippe Rouger; Françoise Roudot-Thoraval; C Férec
Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing.
Journal of virological methods 1999;80(1):33-44.
1999: Jean-Michel Pawlotsky; Michèle Martinot-Peignoux; J D Poveda; Anne Bastie; Veronique Le Breton; Françoise Darthuy; Jocelyne Rémiré; S Erlinger; Daniel Dhumeaux; P Marcellin
Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
Journal of virological methods 1999;79(2):227-35.
1999: Christophe Hézode; Cécile Cazeneuve; O Coué; Françoise Roudot-Thoraval; Jean-Michel Pawlotsky; Elie Serge Zafrani; S Amslem; Daniel Dhumeaux
Hemochromatosis C282Y mutation and histological fibrosis in patients with C virus chronic hepatitis.
Hepatology (Baltimore, Md.) 1999;29(4):1338.
1999: Jean-Michel Pawlotsky
Diagnostic tests for hepatitis C.
Journal of hepatology 1999;31 Suppl 1():71-9.
1998: Jean-Jacques Lefrère; J Coste; Christine Defer; Bernard Mercier; C Férec; Pascale Loiseau; E Portelette; Martine Mariotti; Joëlle Lerable; Philippe Rouger; Jean-Michel Pawlotsky
Screening blood donations for viral genomes: multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection.
Transfusion 1998;38(10):915-23.
1998: Jean-Michel Pawlotsky; Isabelle Lonjon; Christophe Hezode; B Raynard; Françoise Darthuy; J Remire; CJ Soussy; Daniel Dhumeaux
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?
Hepatology (Baltimore, Md.) 1998;27(6):1700-2.
1998: Jean-Michel Pawlotsky
Genetic heterogeneity and properties of hepatitis C virus.
Acta gastro-enterologica Belgica 1998;61(2):189-91.
1998: Jean-Michel Pawlotsky; Muriel Pellerin; M Bouvier; Françoise Roudot-Thoraval; Georgios Germanidis; Anne Bastie; Françoise Darthuy; Jocelyne Rémiré; CJ Soussy; Daniel Dhumeaux
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Journal of medical virology 1998;54(4):256-64.
1998: Jean-Michel Pawlotsky; Georgios Germanidis; Avidan U Neumann; Muriel Pellerin; PO Frainais; Daniel Dhumeaux
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.
Journal of virology 1998;72(4):2795-805.
1998: Jean-Michel Pawlotsky; D R Gretch
Molecular tools for the treatment of hepatitis C.
Antiviral therapy 1998;3(Suppl 3):45-55.
1998: Jean-Pierre Zarski; Benoit Bohn; Anne Bastie; Jean-Michel Pawlotsky; Maryline Baud; F Bost-Bezeaux; Jeanne Tran Van Nhieu; Jean-Marie Seigneurin; C Buffet; Daniel Dhumeaux
Characteristics of patients with dual infection by hepatitis B and C viruses.
Journal of hepatology 1998;28(1):27-33.
1998: Jean-Michel Pawlotsky; Françoise Roudot-Thoraval; A Scott Muerhoff; Muriel Pellerin; Georgios Germanidis; Suresh M Desai; Anne Bastie; Françoise Darthuy; Jocelyne Rémiré; Elie Serge Zafrani; CJ Soussy; Isa K Mushahwar; Daniel Dhumeaux
GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
Journal of medical virology 1998;54(1):26-37.
1998: Christophe Hezode; Cécile Cazeneuve; O Coué; Jean-Michel Pawlotsky; Elie Serge Zafrani; Serge Amselem; Daniel Dhumeaux
Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C.
Hepatology (Baltimore, Md.) 1998;27(1):306.
1997: Marc Bogard; Claudine Buffet-Janvresse; Jean-François Cantaloube; Philippe Biagini; Gilles Duverlie; Sandrine Castelain; Jacques Izopet; M Dubois; Christine Defer; I Lepot; J Coste; P Marcellin; Michèle Martinot-Peignoux; Philippe Halfon; Victoria Gerolami; L Frangeul; Jean-Michel Pawlotsky; Françoise Roudot-Thoraval; Elisabeth Dussaix; Pascale Loiseau; N Ravera; P Lewin; J Lamoril; Joëlle Lerable; P Lebon
GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum.
Journal of clinical microbiology 1997;35(12):3298-300.
1997: LE Prescott; A Berger; Jean-Michel Pawlotsky; P Conjeevaram; I Pike; Peter Simmonds
Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
Journal of medical virology 1997;53(3):237-44.
1997: Françoise Roudot-Thoraval; Anne Bastie; Jean-Michel Pawlotsky; Daniel Dhumeaux
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
Hepatology (Baltimore, Md.) 1997;26(2):485-90.
1997: Jean-Michel Pawlotsky
Measuring hepatitis C viremia in clinical samples: can we trust the assays?
Hepatology (Baltimore, Md.) 1997;26(1):1-4.
1997: Jean-Michel Pawlotsky; L Prescott; P Simmonds; C Pellet; P Laurent-Puig; C Labonne; Françoise Darthuy; J Remire; J Duval; C Buffet; J P Etienne; Daniel Dhumeaux; E Dussaix
Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay.
Journal of clinical microbiology 1997;35(7):1734-9.
1997: Jean-Michel Pawlotsky; Anne Bastie; Isabelle Lonjon; Jocelyne Rémiré; Françoise Darthuy; CJ Soussy; Daniel Dhumeaux
What technique should be used for routine detection and quantification of HBV DNA in clinical samples?
Journal of virological methods 1997;65(2):245-53.
1997: Jean-Michel Pawlotsky
[Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?].
Gastroentérologie clinique et biologique 1997;21(1 Pt 2):S41-50.
1997: Marie-Pierre Bralet; Françoise Roudot-Thoraval; Jean-Michel Pawlotsky; Anne Bastie; Jeanne Tran Van Nhieu; J Duval; Daniel Dhumeaux; Elie Serge Zafrani
Histopathologic impact of GB virus C infection on chronic hepatitis C.
Gastroenterology 1997;112(1):188-92.
1996: Christophe Duvoux; Jean-Michel Pawlotsky; Daniel Cherqui; JM Métreau; Pierre-Louis Fagniez; J Duval; Daniel Dhumeaux
Initial clinical patterns of hepatitis C virus reinfection after liver transplantation for hepatitis C virus-related cirrhosis.
Transplantation proceedings 1996;28(5):2844-5.
1996: Jean-Michel Pawlotsky; Françoise Roudot-Thoraval; Anne Bastie; Françoise Darthuy; Jocelyne Rémiré; JM Métreau; Elie Serge Zafrani; J Duval; Daniel Dhumeaux
Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.
The Journal of infectious diseases 1996;174(1):1-7.
1996: Jean-Michel Pawlotsky; Françoise Roudot-Thoraval; Anne Bastie; C Pellet; J Duval; Daniel Dhumeaux
Are hepatitis C virus genotypes 1a and 1b so different?
Hepatology (Baltimore, Md.) 1996;23(5):1289-91.
1996: Jean-Michel Pawlotsky; F Lunel; J P Zarski; P Laurent-Puig; C Bréchot
[Biological diagnosis of hepatitis C virus infection. Role of serological and molecular tests].
Gastroentérologie clinique et biologique 1996;20(2):146-61.
1996: Jean-Michel Pawlotsky; A G Hovanessian; Françoise Roudot-Thoraval; N Robert; M Bouvier; G Babany; J Duval; Daniel Dhumeaux
Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Antimicrobial agents and chemotherapy 1996;40(2):320-4.
1996: G Rostoker; Jean-Michel Pawlotsky; Anne Bastie; B Weil; Daniel Dhumeaux
Type I membranoproliferative glomerulonephritis and HCV infection.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 4():22-4.
1996: Jean-Michel Pawlotsky; Anne Bastie; C Pellet; J Remire; Françoise Darthuy; L Wolfe; C Sayada; J Duval; Daniel Dhumeaux
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
Journal of clinical microbiology 1996;34(1):80-3.
1996: Lawrence Serfaty; Olivier Chazouillères; Jean-Michel Pawlotsky; T Andreani; C Pellet; Raoul Poupon
Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity.
Gastroenterology 1996;110(1):291-5.
1995: Jean-Michel Pawlotsky; Françoise Roudot-Thoraval; Anne Bastie; J Duval; Daniel Dhumeaux
Are basal core-IgM antibodies to hepatitis C virus predictive of successful alpha-interferon therapy?
Journal of hepatology 1995;23(6):760-1.
1995: Jean-Michel Pawlotsky; M Bouvier; Patricia Fromont; L Deforges; J Duval; Daniel Dhumeaux; Philippe Bierling
Hepatitis C virus infection and autoimmune thrombocytopenic purpura.
Journal of hepatology 1995;23(6):635-9.
1995: Jean-Michel Pawlotsky; Françoise Darthuy; Jocelyne Rémiré; C Pellet; L Udin; Lieven Stuyver; Françoise Roudot-Thoraval; Christophe Duvoux; Catherine Douvin; Ariane Mallat
Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Journal of medical virology 1995;47(3):285-91.
1995: Lieven Stuyver; A Wyseur; W van Arnhem; Françoise Lunel; P Laurent-Puig; Jean-Michel Pawlotsky; Bernhard Kleter; Leda Bassit; J Nkengasong; Leen-Jan van Doorn
Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.
Virus research 1995;38(2-3):137-57.
1995: Jean-Michel Pawlotsky; A Hovanessian; Françoise Roudot-Thoraval; P Lebon; N Robert; M Bouvier; G Babany; J Duval; Daniel Dhumeaux
Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(10):857-62.
1995: Jean-Michel Pawlotsky; H Benchiki; C Pellet; J Duval; Daniel Dhumeaux; J Revuz; M Bagot
Lichen planus and hepatitis C virus (HCV)-related chronic hepatitis: evaluation of HCV genotypes.
The British journal of dermatology 1995;133(4):666-7.
1995: Jean-Michel Pawlotsky; Daniel Dhumeaux; Martine Bagot
Hepatitis C virus in dermatology. A review.
Archives of dermatology 1995;131(10):1185-93.
1995: Christophe Duvoux; Jean-Michel Pawlotsky; Daniel Cherqui; Jeanne Tran Van Nhieu; J M Metreau; Pierre-Louis Fagniez; J Duval; Elie Serge Zafrani; Daniel Dhumeaux
Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection.
Transplantation 1995;60(5):457-61.
1995: Jean-Michel Pawlotsky; Laurent Bélec; Gérard Grésenguet; L Deforges; M Bouvier; J Duval; Daniel Dhumeaux
High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic.
Journal of medical virology 1995;46(3):269-72.
1995: Jean-Michel Pawlotsky; L Tsakiris; Françoise Roudot-Thoraval; C Pellet; Lieven Stuyver; J Duval; Daniel Dhumeaux
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.
The Journal of infectious diseases 1995;171(6):1607-10.
1995: Jean-Michel Pawlotsky; Françoise Roudot-Thoraval; C Pellet; P Aumont; Françoise Darthuy; J Remire; J Duval; Daniel Dhumeaux
Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.
Journal of clinical microbiology 1995;33(5):1357-9.
1995: Jean-Michel Pawlotsky; Françoise Roudot-Thoraval; P Simmonds; J Mellor; M B Ben Yahia; C André; M C Voisin; Liliane Intrator; E S Zafrani; J Duval; D Dhumeaux
Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes.
Annals of internal medicine 1995;122(3):169-73.
1995: Jean-Michel Pawlotsky; J Remire; Françoise Darthuy; Liliane Intrator; L Udin; Daniel Dhumeaux; J Duval
Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor?
Journal of medical virology 1995;45(1):68-70.
1994: Jérôme Lamoril; F Lunel; P Laurent-Puig; Christine Defer; Pascale Loiseau; Jean-Jacques Lefrère; Jean-Michel Pawlotsky; P Marcellin; F Bouchardeau; Marc Bogard
Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. Group d'Etudes Moléculaires des Hépatites (GEMHEP).
Journal of hepatology 1994;21(1):133-4.
1994: Jean-Michel Pawlotsky; A Fleury; V Choukroun; L Deforges; Françoise Roudot-Thoraval; P Aumont; J Duval; Daniel Dhumeaux
Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
Journal of clinical microbiology 1994;32(5):1357-9.
1994: Jean-Michel Pawlotsky; M Ben Yahia; C Andre; M C Voisin; Liliane Intrator; Françoise Roudot-Thoraval; L Deforges; Christophe Duvoux; Elie Serge Zafrani; J Duval
Immunological disorders in C virus chronic active hepatitis: a prospective case-control study.
Hepatology (Baltimore, Md.) 1994;19(4):841-8.
1994: C Jubert; Jean-Michel Pawlotsky; F Pouget; C Andre; L DeForges; Stephane Bretagne; J P Mavier; J Duval; J Revuz; Daniel Dhumeaux
Lichen planus and hepatitis C virus--related chronic active hepatitis.
Archives of dermatology 1994;130(1):73-6.
1994: Jean-Michel Pawlotsky; P Marcellin; C Trépo; Daniel Dhumeaux
[Treatment of viral hepatitis C].
Gastroentérologie clinique et biologique 1994;18(4):362-73.
1993: Françoise Roudot-Thoraval; Jean-Michel Pawlotsky; V Thiers; L Deforges; P P Girollet; F Guillot; C Huraux; P Aumont; C Brechot; Daniel Dhumeaux
Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing.
Hepatology (Baltimore, Md.) 1993;17(5):772-7.
1993: Jean-Michel Pawlotsky; L Deforges; Stephane Bretagne; C André; JM Métreau; V Thiers; Elie Serge Zafrani; M Goossens; J Duval; J P Mavier
Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis.
Gut 1993;34(2 Suppl):S66-8.
1993: Françoise Roudot-Thoraval; Jean-Michel Pawlotsky; L Deforges; P P Girollet; Daniel Dhumeaux
Anti-HCV seroprevalence in pregnant women in France.
Gut 1993;34(2 Suppl):S55-6.
1992: Jean-Michel Pawlotsky; C Andre; J M Metreau; M Beaugrand; Elie Serge Zafrani; Daniel Dhumeaux
Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1992;16(1):127-31.